Licensing & Technology Transfer

PROFILE Life Sciences (PLS) is expert in understanding the commercial value of technology and provides the expertise necessary to establish a venture, research potential markets, negotiate highest value for technologies and to assure its successful transfer.

Based on a detailed analysis of the intellectual property, the markets, and the available resources of the client, the optimum strategy of commercialization is determined by PLS. This could be the licensing on an ongoing royalty basis, the sale of IP rights or a combination of both in different markets.

R&D

Diagnostics

PLS is expert in biomarker assay development (ELISA, IFT, WB, PCR, multiplex testing, arrays), recombinant protein and monoclonal and single chain antibody based technologies for drug screening, diagnostic laboratories, POC testing and immunhistology.

Pharma

PLS has successful experience in developing drugs in areas such as cardiovascular disease, diabetes & lipid metabolism, osteoporosis, inflammatory diseases (HTS, ADME, Animal models), recombinant proteins and genetically altered virus (gene therapy).

PLS has proven experience in clinical drug development.

Business Development

PLS analyzes market, customer and competitor trends, assesses partnering opportunities and prepares business plans for novel subsidiaries, initiates academic partnerships, and cooperates with opinion leaders.